Researchers at Université catholique de Louvain discovered a bacterium, Dolosigranulum pigrum, that reduces the persistence of symptoms characteristic of long Covid. The study found that this bacterium is associated with improved recovery following viral respiratory infections.
Researchers have uncovered a microbial metabolite called trimethylamine (TMA) that can block a key immune pathway and improve blood sugar control. TMA, produced by gut bacteria from dietary choline, targets IRAK4, a protein that triggers inflammation and insulin resistance in diabetic individuals.
A study by neuroscientists found that babies born blind retain the ability to recognize faces and objects, but not small details like contours, in their brains. The research suggests that early vision loss may not hinder brain development as much as previously thought, paving the way for new visual therapies.
The study found that the presence of microbiota increases tacrolimus levels in the blood, reducing the risk of rejection but also increasing side effects. Clinical tests revealed two specific types of bacteria associated with reduced tacrolimus dosages, and a link between Anaerostipes bacteria and diabetes prevention.
A team of researchers at Université catholique de Louvain has discovered a way to block the spike protein of SARS-CoV-2, preventing infection and offering potential long-term protection against COVID. The breakthrough involves using multivalent glycoclusters that bind strongly to the virus's surface, effectively 'locking' it out of cells.
Researchers at Université catholique de Louvain have discovered a drug called MitoQ that prevents the appearance of metastases and local recurrences in human breast cancer. The molecule stops cancerous stem cells from awakening, offering a new treatment option for patients.
Bacteria use lipoproteins, which contain a soft, unstructured 'spaghetti' segment, to protect themselves from invaders. Removing or altering this segment weakens the bacteria, making it an important target for new antibiotic treatments.
Researchers at Université catholique de Louvain discovered that DHA slows the development of tumors by poisoning cancer cells through a phenomenon called ferroptosis. This mechanism is triggered when acidotic tumor cells absorb excessive amounts of unsaturated fatty acids, leading to cell death.
Researchers discovered a new bacterium, Dysosmobacter welbionis, present in 70% of the population, which produces butyrate and has anti-inflammatory effects. The bacteria was found to increase mitochondrial activity, lowering sugar levels and weight in mice, suggesting potential for treating type 2 diabetes and obesity.
Researchers evaluated thousands of policy proposals to assess feasibility and potential impact on reducing EU's contribution to tropical deforestation. Two promising policy options are implementing due diligence for importers and supporting multi-stakeholder forums.
An international study published in Affective Science found that Western countries are the most affected by parental burnout, with individualism playing a predominant role. The study suggests that collectivist cultures, like those in Africa, may protect against parental burnout due to their emphasis on community and mutual aid.
Researchers discovered that twisted graphene at a 1.1-degree angle produces superconductivity, allowing for efficient electricity transport without resistance. The magic angle creates a moiré effect, trapping electrons and phonons in domains that enable superconducting properties.
New research reveals that European colonization significantly increased rates of soil erosion and alluvium accumulation in North America, with impacts felt for centuries.
Researchers at Université catholique de Louvain have discovered a link between the brain and intestinal bacteria that plays a crucial role in regulating sugar levels in the blood. The study found that a particular lipid acts on the gut 'second brain' to restore communication and reduce diabetes risk.
Researchers at Université catholique de Louvain have discovered a molecule that blocks immune responses in cancer patients, and are now developing an immunotherapy to neutralize it. The treatment combines anti-GARP antibodies with another proven approach to increase effectiveness in fighting cancer.
Scientists have caught BAM guard towers red-handed, revealing their role in bacterial resistance to antibiotics. This discovery provides unprecedented insight into the mechanism of bacteria, offering a new angle for targeting BAM during antibiotic treatment.
Researchers at Université catholique de Louvain discovered that cancer cells can deactivate the CD166 'Velcro' protein on their surface, allowing them to migrate more easily and form metastases. This fundamental mechanism may lead to the development of new solutions to block metastasis and slow down cancer progression.
Cancer cells store lipids in vesicles called lipid droplets, making them more invasive and prone to forming metastases. The researchers found that TGF-beta2 is the switch responsible for both lipid storage and aggressive cancer cell behavior.
Researchers at UCLouvain have made breakthroughs in understanding the immune system's role in cancer. They developed a new drug targeting immune system cells to stimulate anti-tumour responses, and are now testing it in human clinical trials.
UCLouvain's research developed Multipath TCP to support expanding global internet traffic, improving Wi-Fi and mobile network switching. The protocol is used by 800 million iPhones and has won international awards, enhancing connectivity in rural areas and offering a win-win for subscribers and telecom operators.
Véronique Dehant's research aims to understand Mars' core, which is essential for determining the planet's habitability and potential for life. The ExoMars mission will collect Martian radio science data and analyze the planet's rotation to gain insights into its innards.
Researchers from UCLouvain have discovered a new material, LiTi2(PS4)3 or LTPS, which shows the highest lithium diffusion coefficient ever measured in a solid. This discovery is an important step towards developing all-solid-state batteries with improved performance.
Researchers have identified a protein, TSPYL5, that allows cancer cells to survive indefinitely. Targeting this protein may help develop new therapies for children with ALT-type cancer, which currently lacks effective treatments.
Researchers at UCLouvain discovered that consuming Akkermansia bacteria in the form of a food supplement can prevent deterioration of health status and lower inflammation markers. The study found improvements in cholesterol levels, body weight, and metabolic parameters in volunteers with pre-diabetes and cardiovascular risk factors.
Researchers at Université catholique de Louvain develop a new therapeutic agent that stimulates the immune system to target cancer cells by blocking immunosuppressive T-lymphocytes. This approach could lead to improved treatment efficiency for cancer patients and potentially treat other diseases with insufficient immunity.
Researchers at UCL discovered how a protein, RcsF, triggers an alarm system in bacteria to defend against antibiotics. This discovery provides a new target for developing new antibiotics and could help combat the growing problem of antibiotic resistance.
A new clinical trial demonstrates that transcranial direct current stimulation (tDCS) improves motor learning and retention in hemiparetic stroke patients. The study used functional MRI to record cerebral activity, showing a significant improvement in motor performance after real tDCS stimulation.
Researchers discovered that the intestinal immune system controls energy metabolism and can modify intestinal bacteria to prevent obesity and diabetes. By disabling a protein called MyD88, the team showed that mice can lose weight and reduce inflammation.
Researchers from Universite catholique de Louvain and Stanford University have synthesized a molecule with exceptional electronic properties, allowing for miniaturized devices. The discovery could lead to new miniaturization opportunities for future computers and green devices.
Researchers at Université catholique de Louvain successfully identified a family of pharmaceutical compounds that prevent the formation of human tumor metastasis. The study found that mitochondria can promote cell migration leading to metastasis, which can be blocked by specific antioxidants.